Comprehensive Study Guide on Neoplasia and Oncology Fundamentals of Oncology

Fundamentals of Neoplasia

Definition of Neoplasia: An abnormal mass of tissue whose growth exceeds and is uncoordinated with that of normal tissue. It persists even after the cessation of the causative stimuli.
The Genetic Balance of Growth: Normal cellular function requires a precise balance between several categories of genes:
- Proto-oncogenes: Genes that, upon stimulation, lead to cellular proliferation.
- Tumor Suppressor Genes: Genes that, upon stimulation, stop excessive proliferation.
- Survival Genes (Anti-apoptotic Genes): These determine the duration of a cell's survival.
- Suicide Genes (Pro-apoptotic Genes): These lead to programmed cell death (apoptosis).
Causes of Neoplastic Transformation: A cell becomes neoplastic due to mutations in these genes leading to:
1. Overstimulation of proto-oncogenes (becoming oncogenes).
2. Suppression of tumor suppressor genes.
3. Overstimulation of anti-apoptotic genes.
4. Suppression of pro-apoptotic genes.
DNA-Repair Genes: These genes repair defects in other genes. Mutations in DNA-repair genes allow further mutations to accumulate, facilitating oncogenesis.

Components of Neoplasia

A tumor (neoplasia) consists of two basic components:

Parenchyma: These are the neoplastic or transformed cells. The parenchyma is responsible for:
1. Determining the name of the tumor (e.g., squamous cell tumor).
2. Determining the biologic behavior (whether it is benign or malignant).
Stroma: This is organized connective tissue that supports the parenchyma. It is composed of:
1. Dense connective tissue and collagen.
2. Blood vessels.
3. Inflammatory cells.
- Stroma consists of non-transformed cells but provides the support and reactive environment necessary for tumor growth, invasiveness, and spread.
Tumor Consistency Based on Stroma:
1. Soft and Fleshy: Characterized by less stroma and more parenchyma.
2. Desmoplasia: Stroma with excessive collagen production.
3. Scirrhous Tumor: A stony-hard stroma commonly found in certain breast tumors.

Characteristics and Classification of Benign Tumors

General Characteristics: Benign tumors are typically microscopically and grossly "innocent." They are characterized as:
1. Localized: They do not move from the site of origin.
2. Non-invasive: They do not invade adjacent cells.
3. Non-metastatic: Their cells do not lodge off to affect other normal cells.
4. Surgically Removable: They can generally be removed via surgery.
Dangerous Exceptions of Benign Tumors: Certain benign tumors can be life-threatening due to their location:
- Ependymoma: Occurs in the ventricles of the brain; tumor cells can block the flow of cerebrospinal fluid, leading to hydrocephalus.
- Meningioma: Located in the meninges; can cause increased intracranial pressure.
- Atrial Myxoma: Located in the right atrium; can physically block the mitral valve.
- Pheochromocytoma: Located in the adrenal gland; secretes excessive epinephrine, causing hypertensive crises.

Naming Conventions for Benign Neoplasms

Mesenchymal Cell Tumors (Connective Tissue): Generally uses the suffix "-oma."
1. Cartilage: Chondroma.
2. Fibrous tissue: Fibroma.
3. Bone cell: Osteoma.
4. Striated muscle: Rhabdomyoma.
5. Smooth muscle: Leiomyoma.
6. Adipose cell: Lipoma.
7. Endothelium: Hemangioma.
8. Lymph nodes: Lymphangioma.
9. Meninges: Meningioma.
Epithelial Cell Tumors:
- Adenoma: A benign tumor showing a glandular pattern under a microscope. It can be:
  - Derived from glandular epithelium.
  - Derived from non-glandular epithelium (e.g., renal tubular epithelium) but appearing glandular under the microscope (Renal Tubular Adenoma).
- What is a Cystadenoma?: A benign tumor that forms cystic spaces and is lined by glandular epithelium. These often appear as large cystic masses filled with secretion.
- Papilloma: Benign epithelial neoplasms producing finger-like or warty projections (fronds). They are classically derived from stratified squamous epithelium (tongue, pharynx) or urothelium (renal pelvis, ureter, bladder).
- What is a Papillary Cystadenoma?: When a cystadenoma develops septa (internal walls) with finger-like projections protruding into the cystic spaces.
- Polyp: Any mass projecting out of the mucosa of an organ (nose, stomach, colon, uterus) and dangling into the lumen. These can be benign, malignant, or simply inflammatory.
- Adenomatous Polyp: A polyp in the colon that shows glandular structure under the microscope.

Malignant Neoplasms: Sarcomas and Carcinomas

Sarcoma: Malignant tumors derived from mesenchymal (mesoderm) tissues.
1. Fibrosarcoma (fibrous tissue).
2. Liposarcoma (adipose tissue).
3. Chondrosarcoma (cartilage).
4. Osteogenic Sarcoma (bone).
5. Angiosarcoma (blood vessels).
6. Lymphangiosarcoma (lymph vessels).
7. Leiomyosarcoma (smooth muscle).
8. Rhabdomyosarcoma (skeletal muscle).
- Note: Lymphoma (lymphocytes) and Leukemia (WBCs) are also sarcomatous malignancies.
Carcinoma: Malignant tumors derived from epithelial tissues (ectoderm, mesoderm, and endoderm).
- Ectoderm Derivatives: Squamous cell carcinoma, Basal cell carcinoma, Malignant melanoma (skin).
- Mesoderm Derivatives: Renal cell carcinoma (kidney).
- Endoderm Derivatives: Gastric carcinoma (GIT), Bronchial carcinoma (respiratory).
Patterns of Growth in Carcinoma:
1. Adenocarcinoma: Displays a glandular pattern.
2. Papillary Carcinoma: Displays a finger-like pattern.
3. Choriocarcinoma: Derived from the placenta (trophoblasts).

Specialized Tumors: Mixed and Totipotent

Mixed Tumor: A neoplasm containing more than one type of tissue or cell component within the same tumor, but derived from a single germ layer.
- Pleomorphic Adenoma (Mixed tumor of salivary gland): A benign tumor showing epithelial cells and mesenchymal-like tissues (myxoid, cartilaginous, and fibrous areas). It results from divergent differentiation of cells from a single germ layer.
- Wilms Tumor: A malignant mixed tumor of the kidney arising from the metanephric blastema (renal anlage in the embryo), derived from the mesoderm.
Totipotent Tumors (Teratoma): Tumors containing cells from all three germ layers (ectoderm, mesoderm, and endoderm).
- These originate from totipotent germ cells normally present in the ovaries, testes, or abnormal midline embryonic rests.
- Mature Teratoma: A benign, well-differentiated tumor (e.g., dermoid cyst).
- Immature Teratoma / Teratocarcinoma: Malignant and undifferentiated forms (teratocarcinoma is essentially a stem cell cancer).

Molecular Basis and Hallmarks of Cancer

Malignant cells exhibit the following characteristic changes (Hallmarks):

Oncogenes: Mutation in proto-oncogenes results in a "gain of function." These are dominant; mutation in only one allele is sufficient ( $\text{1-hit hypothesis}$ ).
Tumor Suppressor Genes: Mutation results in "loss of function." These are recessive; both alleles must be inactivated for cancer to develop ( $\text{2-hit hypothesis}$ or Knudson's hypothesis).
DNA Repair Genes: Mutation leads to a loss of function, preventing the repair of genetic errors.
Anti-apoptotic Genes: Gain of function leads to increased survival.
Pro-apoptotic Genes: Loss of function prevents cell death.
Telomerase Activation: Gain of function leads to excessive telomerase enzyme, which increases telomere length on chromosomes, providing limitless replication capacity.
Sustained Angiogenesis: Cancerous cells induce surrounding endothelial cells to develop blood vessels to support growth.
Invasion: Cells infiltrate adjacent tissues beyond anatomical boundaries.
Metastasis: Cells lodge off from the primary site, survive in circulation, and grow at secondary sites.
Evasion of Immune Response: Alterations in gene expression allow cells to evade the host immune system.
Altered Metabolism (Warburg Effect): Switch to aerobic glycolysis for macroscopic synthesis.

Specific Oncogenes and Signaling Pathways

Growth Factors: Overproduced by some tumors:
- $\text{PDGF-B}$ (Platelet-derived Growth Factor): Glioblastoma.
- $\text{Fibroblast-GF}$ : Osteosarcoma, stomach cancer.
- $\text{TGF-}\alpha$ : Glioblastoma.
- $\text{HGF}$ : Hepatocellular and thyroid carcinoma.
Growth Factor Receptors:
- $\text{ERBB1}$ (EGFR): Lung, pancreatic, and colon cancer.
- $\text{ERBB2}$ ( $\text{HER2/neu}$ ): Present in breast cancer.
Signal Transduction Proteins (RAS):
- Normally, RAS state is cycled by $GTP$ (Active) and $GDP$ (Inactive).
- RAS has intrinsic $GTPase$ activity (the "off button") facilitated by $GAPs$ (GTPase Activating Proteins).
- Mutation in $RAS$ prevents $GTP$ hydrolysis, keeping RAS permanently active.
- Mutation in $NF1$ (a tumor suppressor) also prevents the "off switch," leading to uncontrolled proliferation.
BCR-ABL (Philadelphia Chromosome):
- A translocation between chromosome $9$ ( $ABL$ gene) and chromosome $22$ ( $BCR$ gene) creates the $t(9;22)$ hybrid gene.
- This produces a mutant ABL tyrosine kinase that is auto-active/always "on."
- Leads to Chronic Myelogenous Leukemia (CML).
- Treatment: Gleevec (Imatinib) is a designer drug that acts as a mutant ABL-tyrosine kinase inhibitor.
Transcriptional Factors (MYC):
- In Burkitt Lymphoma, a translocation occurs between chromosome $8$ ( $MYC$ ) and chromosome $14$ ( $Ig$ gene).
- The hybrid gene leads to excessive proliferation of B-lymphocytes.
Cell Cycle Control (Cyclin Genes):
- Mutations typically affect the $G_1/S$ checkpoint.
- Gain of function in Cyclin D or CDK4 genes over-activates DNA replication.

Tumor Suppressor Genes and the "Guardian of the Genome"

Retinoblastoma (RB) Gene: The "Governor of Proliferation."
- RB exists in an active, hypo-phosphorylated state where it binds to the transcription factor $E2F$ , preventing the cell cycle.
- When phosphorylated by CDK, RB releases $E2F$ , allowing progression to the S-phase.
p53 Gene: The "Guardian of the Genome."
- Most frequently mutated gene in human cancers.
- Normal Mechanism: Activated by DNA damage, hypoxia, or oncogenic stress (e.g., RAS activation).
- Roles of p53:
  1. Quiescence: Activates $p21$ (a CDK inhibitor), causing cell cycle arrest in the $G_1$ phase.
  2. DNA Repair: Stimulates $GADD45$ to repair damaged DNA. If successful, $MDM2$ is produced to degrade p53.
  3. Senescence: Permanent cessation of cell division.
  4. Apoptosis: If damage is irreparable, p53 activates pro-apoptotic genes like $BAX$ , inducing cell death.
Li-Fraumeni Syndrome: A genetic disorder where a child inherits one defective p53 allele, predisposing them to cancer with only one additional "hit."
p53 Evasion Mechanisms:
- $MDM2$ amplification (degrades p53 protein).
- Human Papilloma Virus (HPV) protein $E6$ binds to and degrades p53.

Metabolism and the Warburg Effect

The Warburg Effect (Aerobic Glycolysis): Even in the presence of ample oxygen, cancer cells preferentially shift glucose metabolism away from oxidative phosphorylation toward glycolysis/fermentation.
- Oxidative Phosphorylation: Generates $36\,ATP$ per glucose but few metabolic intermediates.
- Aerobic Glycolysis: Generates only $2\,ATP$ per glucose but provides metabolic intermediates (RNA, DNA, lipids) required for rapid growth.
- Lactate production results in a low $pH$ , favoring tumor invasion and suppressing immune effectors.
Clinical Application: Solid tumors are "glucose hungry," a property utilized in ${}^{18}\text{F-FDG}$ PET (Positron Emission Tomography) scanning to locate metastatic sites.
Metabolic Triggers:
1. PI3K/AKT Pathway: Increases glucose transporter activity.
2. Receptor Tyrosine Kinase: Inhibits Pyruvate Kinase ( $M_2$ isoform), causing accumulation of intermediates.
3. MYC Gene: Up-regulates glycolytic enzymes and glutaminase.

Mechanisms of Invasion and Metastasis

Metastasis occurs in two phases: Invasion of the Extracellular Matrix (ECM) and Vascular Dissemination.

ECM Invasion Steps:
1. Detachment: Loss of $E-cadherin$ function (junction protein) reduces cell-to-cell adherence.
2. Degradation: Tumor cells release proteolytic enzymes like Matrix Metalloproteinases ( $MMP2$ , $MMP9$ ) and Type IV Collagenase to degrade the basement membrane.
3. Attachment: Cells attach to ECM proteins (Laminin, Fibronectin).
4. Migration: Locomotion is aided by autocrine motility factors, chemokines, and cleavage products of the ECM.
Anoikis: A form of programmed cell death for normal cells that lose attachment to the ECM; cancer cells are resistant to anoikis.
Vascular Dissemination:
- Tumor cells aggregate into clumps (emboli) to survive in circulation.
- Organ Tropism ("Seed and Soil Theory"): Certain tumors prefer specific organs:
  - Colon cancer $\rightarrow$ Liver (via portal circulation).
  - Prostate/Breast cancer $\rightarrow$ Bone marrow.
  - Bronchogenic carcinoma $\rightarrow$ Adrenal glands and Brain.
  - Neuroblastoma $\rightarrow$ Liver and Bones.
- Spleen and muscles are considered "unfavorable soil" despite high blood supply.

Carcinogenesis Factors

Chemical Carcinogenesis:
- Initiation: Exposure to a carcinogen causing permanent, irreversible DNA damage. It has "memory."
- Promotion: Chemicals that are not mutagenic themselves but stimulate the proliferation of mutated cells (clonal expansion).
  - Examples of Promoters: Phorbol esters, hormones (estrogen), phenols, drugs, or inflammatory processes.
Radiation Carcinogenesis:
- UV Radiation: UVB ( $280-320\,nm$ ) causes pyrimidine dimer formation in DNA.
- Ionizing Radiation: X-rays, $\gamma$ -rays, and particles cause DNA strand breaks and translocations.
Microbial Carcinogenesis:
- Human Papilloma Virus (HPV): Types $16$ and $18$ produce oncoproteins $E6$ (inhibits p53) and $E7$ (displaces RB-E2F complex).
- Epstein-Barr Virus (EBV): Infects B-cells via $CD21$ receptors. EBV causes expression of $LMP-1$ and $EBNA-2$ , leading to B-cell proliferation. Translocation of the $MYC$ gene to the $Ig$ gene locus results in Burkitt Lymphoma.

Host Defense and Clinical Staging

Anti-Tumor Mechanisms: Cytotoxic T-Lymphocytes ( $CTLs$ ) and Natural Killer ( $NK$ ) cells recognize tumor antigens (mutated self-proteins, oncofetal antigens like $CEA$ or $AFP$ , or viral proteins).
Immune Evasion: Tumors may lose surface antigens, down-regulate $MHC$ Class I expression, or express inhibitory checkpoints like $PD-L1$ and $CTLA-4$ .
Cancer Cachexia: Progressive loss of body fat and lean muscle mass accompanied by profound weakness, anemia, and anorexia. Driven by cytokines like $TNF$ -$\alpha $,$ IL-1 $, and$ IL-6.\n* **Grading of Tumor**: Based on the degree of differentiation (the extent to which cells resemble normal tissue).\n * G_1: Well-differentiated (low grade).\n * G_4: Undifferentiated/Anaplastic (high grade).\n* **Staging of Tumor (TNM System)**:\n * **T (Tumor Size)**: T_{is} $(in-situ);$ T_1 < 2\,cm $;$ T_2 = 2-5\,cm $;$ T_3 > 5\,cm $;$ T_4 (extension to chest wall/skin).\n * **N (Regional Nodes)**: N_0 $(none);$ N_1 $(movable ipsilateral node);$ N_2 $(fixed nodes);$ N_3 (supraclavicular/internal mammary nodes).\n * **M (Metastasis)**: M_0 $(none);$ M_1$$ (distant metastasis).